New protocol aims to cut death and disability from brain hemorrhage
NCT ID NCT06802588
First seen Jan 17, 2026 · Last updated Jun 18, 2026 · Updated 24 times
Summary
This study looks at whether a dedicated, step-by-step care plan can help people who have a brain bleed (intracerebral hemorrhage). About 600 adults admitted to the University Hospital of Tours will be followed to see if the new protocol reduces deaths and long-term disability compared to usual care. The goal is to improve survival and quality of life after this serious type of stroke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Center of Tours
RECRUITINGTours, 37044, France
Contact Email: •••••@•••••
Contact
-
University Hospital of Angers
RECRUITINGAngers, 49100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital of Poitiers
RECRUITINGPoitiers, 86000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.